Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRV-6527 in moderately to severely active Crohn's disease
2017-003017-25Phase 2Completed
- Sponsor
- Provention Bio
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of edicotinib in Crohn's disease, sponsored by Provention Bio. Started Nov 2017; status: completed.
02
Drugs
edicotinib
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2017-003017-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003017-25.